Combination therapy with VEGFR2 and EGFR siRNA enhances the antitumor effect of cisplatin in non-small cell lung cancer xenografts

Author：                      

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.29, Iss.1, 2013-01, pp. : 260-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

By Schiller J.   Tilden D.   Aristides M.   Lees M.   Kielhorn A.   Maniadakis N.   Bhalla S.  

Lung Cancer, Vol. 43, Iss. 1, 2004-01 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite

Combination of Cisplatin and Interferon- 2a (Roferon(R)-A) in Patients with Non-small Cell Lung Cancer (NSCLC). An Open Phase II Multicentre Study

By Kataja V.   Yap A.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancermediated malignant pleural effusion

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2332-2340

Spandidos Publications

Access to resources Recommend Favorite

Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression

By                      

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 998-1006

Spandidos Publications

Access to resources Recommend Favorite

Paclitaxel, cisplatin, etoposide combination chemotherapy: a multifractionated bolus dose schedule for non-small cell lung cancer

By Lokich J.   Anderson N.   Bern M.   Coco F.   Gotthardt S.   Oliynyk P.   Dow E.  

European Journal of Cancer, Vol. 34, Iss. 5, 1998-04 ,pp. : 659-663

Elsevier

Access to resources Recommend Favorite